ArcherDx's Acquisition

ArcherDx was acquired by Enzymatics on September 06, 2013.

ArcherDX offers a bioinformatics platform for targeted sequencing applications featuring proprietary Anchored Multiplexed PCR (AMP) chemistry in a lyophilized format.…

Articles about ArcherDx's Acquisition: